대장암의 간 전이 진단: 이중시기 CT, Mn-DPDP 조영증강 MRI, 그리고 CT-MRI 종합 판독의 비교
Preoperative Detection of Hepatic Metastases from the colorectal Cancers: Comparison of Dual-phase CT scan, Mn-DPDP enhanced MRI, and combination of CT and MRI
1
조회
0
다운로드
2
인용
0
참고문헌
초록
목적 : 대장암의 간 전이 진단에서 CT와 MRI 단독 판독과 CT-MRI 종합 판독의 성적을 비교하여 부가적인 Mn-DPDP 조영증강 MRI의 유용성에 대해 알아보고자 하였다. 대상 및 방법 : 53명의 대장암 환자를 대상으로 하였으며 이들은 수술전 이중시기 CT에서 전 이성 병소가 의심되거나 혈청 CEA(carcinoembryonic antigen) 수치가 10 ng/mL 로 증가하여 부가적인 Mn-DPDP 조영증강 MRI를 시행하였다. 두 명의 방사선과 의사가 독립적으로 15 일 간격을 두고 CT 단독 판독, MRI 단독 판독, CT와 MRI를 종합하여 판독하였다. 각 병변의 크기, 위치, 악성 유무를 평가하였으며 크기에 따라 1 cm 미만(A 그룹), 1 cm 에서 2 cm 미만(B 그룹), 2 cm 이상(C 그룹)의 세 그룹으로 분류하였다. ROC 곡선을 이용하여 진단적 정확도를 비교하였으며 발견율과 위양성율을 구하여 통계적 유의성을 검증하였다. 결과 : A 그룹에서 CT와 MRI를 종합하여 판독한 경우는 CT, MRI를 단독으로 판독한 경우와 비교하여 병변의 발견율이 유의하게 높았다 (82%, p = 0.036 ). B그룹에서는 CT와 MRI 를 종합하여 판독한 경우 CT를 단독으로 판독한 경우와 비교하여 Az 값이 유의하게 낮았으 며(<1 cm, p=0.034; 1-2 cm, p=0.045) MRI 단독 판독과 비교하여서는 유의한 차이를 보이지 않았다. 위양성율에 있어서는 CT 단독 판독의 경우, CT와 MRI의 종합 판독과 비교하여A그룹에서 유의하게 높은 결과를 보였다 (28 %, p=0.023). 결론 : 대장암 환자에서 병기결정에 있어서 일반적으로 행해지는 나선형 CT 외에 부가적 Mn-DPDP 조영증강 MRI는 2 cm 미만의 간 병변의 감별에 있어 유용하며, 특히 1cm 미만의 작은 간 전이 발견에 있어서는 CT 또는 MRI 단독 판독의 경우보다 발견율을 높일 수 있어서 유용할 것으로 생각된다.
Abstract
Purpose : To determine the usefulness of additional Mn-DPDP MRI for preoperative evaluation of the patients with colorectal cancers by comparison of dual-phase CT scan, Mn-DPDP enhanced MRI and combination of CT and MRI. Materials and Methods : Fifty-three colorectal cancer patients with 92 metastatic nodules underwent dualphase (arterial and portal) helical CT scan and Mn-DPDP MRI prior to surgery. The indication of MRI was presence or suspected of having metastatic lesions at CT scan and/or increased serum carcinoembryonic antigen (CEA) levels (10 ng/mL or more). The diagnosis was established by the combination of findings at surgery, intraoperative ultrasonography, and histopathologic examination. Two radiologists interpreted CT, MRI, and combination of CT-MRI at discrete sessions and evaluated each lesion for location,size, and intrinsic characteristics. The lesions were divided into three groups according to their diameter; 1cm <, 1-2 cm, and > 2 cm. Diagnostic accuracy was evaluated using the alternative-free response receiver operating characteristic method. Detection and false positive rate were also evaluated. Results : In the lesions smaller than 1 cm, detection rate of combined CT-MRI was superior to CT or MRI alone (82%, p = 0.036). The mean accuracy (Az values) of combined CT and MRI was significantly higher than that of CT in the lesions smaller than 2 cm (1 cm <, p=0.034; 1-2 cm,p=0.045). However, there was no significant difference between MRI and combined CT-MRI. The false positive rate of CT was higher than those of combined CT-MR in the lesions smaller than 1 cm (28 %, p=0.023). Conclusion : Additional MRI using Mn-DPDP besides routine CT scan was helpful in differentiating the hepatic lesions (< 2 cm) and could improve detection of the small hepatic metastases (< 1 cm) from colorectal carcinoma.
참고문헌 (27)
- "Resection of the liver for colorectalcarcinoma metastases", pp.1~
- "Liver resection for colorectal metastases", 15, pp.938~946 (1997)
- "Portal-phase contrast-enhnaced helical CTfor the detection of malignant hepatic tumors sensitivity basedon comparison with intraoperative and pathologic findings", 166, pp.91~95 (1996)
- "Hepatic metastases from colorectal cancer preoperative detectionand assessment of respectability with helical CT", 218, pp.55~60 (2001)
- "Patients with ColorectalCancer Relationship between Size of metastases, standard of reference, and detection rates", 224, pp.404~409 (2002)
- "Multidetector row helical CTin preoperative assessment of small (<1.5 cm) liver metastases: is thinner collimation better?", 225, pp.137~142 (2002)
- "Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement", 13, pp.397~401 (2001)
- "Detection of hepatic metastases ferumoxidesenhancedMR imaging versus unenhanced MR imaging andCT during arterial portography", 200, pp.785~792 (1996)
- "comparison of MR imaging after the administrationof superparamagnetic iron oxide with dual-phase CT byusing alternative free response receiver operating characteristicanalysis", 210, pp.459~466 (1999)
- "Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis", 217(1), pp.152~158 (2000)
- "Ferumoxides-enhanced double-echo T2-weighted MRimaging in differentiating metastases from nonsolid benign lesionsof the liver", 225(1), pp.151~158 (2002)
- "Small(<2cm) hepatic lesions in colorectal cancer patients: detection and characterization on Mangafodipir Trisodium-enhanced MRI", 182, pp.1233~1240 (2004)
- "Liver lesions: manganese enhanced MR and dual phase helical CT for preoperative detection and characterization- comparison with receiver operating characteristic analysis", 223, pp.525~531 (2002)
- "MR imaging in the evaluation of hepaticmetastases", 8, pp.741~756 (2000)
- "MangafodipirTrisodium 조영 후 간MR 영상에서 전이성 간암의 진단을 위해지연기 영상은 꼭 필요한가? 원발성 간세포암과 비교", 51, pp.299~305 (2004)
- "Efficacy and safety of mangafodipir trisodium (MnD-PDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials?efficacy of early imaging", 12(5), pp.689~701 (2000)
- "Characterization of Liver Lesions with Mangafodipir Trisodium?enhanced MR Imaging: multicenter Study Comparing MR and Dual-Phase Spiral CT", 223(2), pp.517~524 (2002)
- "Prevalence and importance of small hepatic lesionsfound at CT in patients with cancer", 210, pp.71~74 (1999)
- "Hepatic lesion detection after superparamagnetic iron oxideenhancement comparison of five T2-weighted sequences at1 0 T by using alternative-free response receiver oprating characteristicanalysis", 214(1), pp.159~166 (2000)
- "Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability", 8, pp.573~579 (2001)
- "Recurrent tumor afterresection of hepatic metastases from colorectal carcinoma-locationand time of discovery as determined by CT", pp.~97 (1994)
- "MR imaging of hepaticmetastases", 10, pp.15~29 (2002)
- "Evaluation of hepatic metastases from colorectalcarcinoma with MR-superparamagnetic iron oxide", 23(1), pp.53~60 (2004)
- "Surgicaltreatment of hepatic metastases impact of intraoperative ultrasound", pp.511~514
- "Detectionof liver metastases from colorectal cancer comparison of interoperativeUS and CT during arterial portography", pp.541~544
- "MRImeasurement of hepatocyte toxicity using the new MRI contrastagent managanese dipyridoxal diphosphate", pp.1~3, Matkin C
- "Influence of the hepatobiliary contrast agent mangafodipirtrisodium(MN-DPDP) on the imaging properties of abdominal organs.", 16, pp.925~931 (1998)